{"id":7132,"date":"2013-06-03T07:49:43","date_gmt":"2013-06-03T11:49:43","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=7132"},"modified":"2013-06-03T07:49:43","modified_gmt":"2013-06-03T11:49:43","slug":"transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132","title":{"rendered":"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48%"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/03\/2013 (wallstreetpr) &#8211;\u00a0The shares of Transition Therapeutics Inc. USA (NASDAQ:TTHI) had gained 9.48 percent to close at $3.35 per share for the last trading session on Friday. The shares of the company had been trading in the range of $3.03 to $3.40 per share during the day, before closing at $0.29 per share higher than previous close on Thursday. The shares of Transition Therapeutics Inc. USA (NASDAQ:TTHI) had recorded 52 week high price level of $3.84 per share and 52 week low price level of $1.78 per share.<\/p>\n<p style=\"text-align: justify;\">Transition Therapeutics Inc. USA (NASDAQ:TTHI) is a bio pharmaceutical company which is focused on the development and commercialization of novel therapeutics for disease indications in large markets. The company presently has many therapeutic technologies in development which include ELND005 (AZD-103) for the treatment of Alzheimer\u2019s disease and bipolar disorder; TT-401\/402 for the treatment of diabetes ,and TT-301 and TT-302 which may have a therapeutic effect on diseases including arthritis, neuropathic pain, Alzheimer\u2019s disease, traumatic brain injury and intracerebral haemorrhage.<\/p>\n<p style=\"text-align: justify;\">Further, Transition Therapeutics Inc. USA (NASDAQ:TTHI) also holds a wholly owned subsidiary, Waratah Pharmaceuticals Inc. to focus on the development and commercialization of ELND005 (AZD-103); the type II diabetes drug candidate TT-401; and TT-301 and TT-302.<\/p>\n<p style=\"text-align: justify;\">The shares of Transition Therapeutics Inc. USA (NASDAQ:TTHI) had recently surged to heavy volumes with nearly 160,459 shares being traded on Friday, while the average trading volume for the company is at 141,458 shares per day. The company presently holds 26.92 million shares outstanding in the market.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/03\/2013 (wallstreetpr) &#8211;\u00a0The shares of Transition Therapeutics Inc. USA (NASDAQ:TTHI) had gained 9.48 percent to close at $3.35 per share for the last [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":7133,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2411,2410],"stock_ticker":[],"class_list":["post-7132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqtthi","tag-transition-therapeutics-inc-usa-nasdaqtthi","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48% - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48% - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/03\/2013 (wallstreetpr) &#8211;\u00a0The shares of Transition Therapeutics Inc. USA (NASDAQ:TTHI) had gained 9.48 percent to close at $3.35 per share for the last [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-03T11:49:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48%\",\"datePublished\":\"2013-06-03T11:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\"},\"wordCount\":256,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg\",\"keywords\":[\"NASDAQ:TTHI\",\"Transition Therapeutics Inc. USA (NASDAQ:TTHI)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\",\"name\":\"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48% - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg\",\"datePublished\":\"2013-06-03T11:49:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48% - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132","og_locale":"en_US","og_type":"article","og_title":"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48% - Wall Street PR","og_description":"Boston, MA 06\/03\/2013 (wallstreetpr) &#8211;\u00a0The shares of Transition Therapeutics Inc. USA (NASDAQ:TTHI) had gained 9.48 percent to close at $3.35 per share for the last [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-06-03T11:49:43+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48%","datePublished":"2013-06-03T11:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132"},"wordCount":256,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg","keywords":["NASDAQ:TTHI","Transition Therapeutics Inc. USA (NASDAQ:TTHI)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132","url":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132","name":"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48% - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg","datePublished":"2013-06-03T11:49:43+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/06\/transitions.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/transition-therapeutics-inc-usa-nasdaqtthi-shares-up-by-9-48-7132#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Transition Therapeutics Inc. USA (NASDAQ:TTHI) shares up by 9.48%"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/7132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=7132"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/7132\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/7133"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=7132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=7132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=7132"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=7132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}